Overview

Multimodal Imaging Market is poised to value over USD 3.4 billion by 2027 end with a CAGR of over 4.3% during the forecast period 2020 to 2027. 

Advancements in diagnostic imaging technology, broadened range of applications in multimodal imaging systems, increased research funding, favourable reimbursement policies, increased research and development in radiotracers and rise in the insurance coverage are the key driving factors of the market. Multimodal imaging is mainly used for drug discovery and in non-invasive and invasive surgical procedures which shall augment the multimodal imaging market growth. The optical fluorescence imaging has garnered a huge demand as it is very efficient in providing real-time images. This imaging method is used extensively for studying molecular events which is why it is often deployed in surgeries that require image guidance. All these factors shall bolster the growth of the market.

Market Segmentation:

By Technology
•    PET-CT
•    SPECT-CT
•    PET-MR
•    OCT
•    Trimodal       
By Application
•    Cardiology
•    Brain and Neurology
•    Ophthalmology
•    Oncology
•    Others    
By End User 
•    Hospitals
•    Diagnostic Imaging Centers
•    Other End Users    
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into technology, application, end user and region. The technology segment is fragmented into PET-CT, SPECT-CT, PET-MR, OCT and Trimodal. The PET-CT systems held the largest multimodal imaging market share owing to the rising insistence for accurate and early diagnosis of cancer, increased clinical evidence for detecting Alzheimer’s disease as early as possible. The application segment is divided into cardiology, brain and neurology, ophthalmology, oncology and other applications. The oncology segment is predicted to dominate the market owing to the rising incidence of cancer across the world, extensive usage of multimodal system for diagnosing tumors. The end user segment is bifurcated into diagnostic imaging centres, hospitals and other end users. The hospital segment subjugated the market owing to increased installations of advanced imaging systems such as SPECT-CT and PET-CT, increased demand for diagnostic processes that are non-invasive in nature. 

Regional Analysis:

The North America region is expected to lead the market owing to the integration of advanced multimodal imaging systems in hospital settings, improves reimbursement scenario, increased financial assistance pertaining to the novel imaging systems. However, the Asia Pacific region is predicted to grow at a substantial rate during the forecast period and this can be credited to improvements in the healthcare infrastructure, increasing patient population and improving insurance coverage policies. 

Competitive Landscape:                            

Some of the prominent market players are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Inc., United Imaging Healthcare Co. Ltd., Mediso Medical Imaging Systems Kft, Neusoft Medical Systems Co. Ltd., Infraredx Inc., Spectrum Dynamics Medical, Topcon Corporation, Heidelberg Engineering, Carl Zeiss AG, Optovue Inc., Nidek Co., Ltd., Optos Plc (UK) (a part of Nikon Corporation), Kowa Company, Ltd.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global multimodal imaging market by technology, by application, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions   

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com  

Table of Contents

1. Market Introduction
           1.1 Objectives of the Study 
           1.2 Market Definition 
           1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
           1.4 Currency
           1.5 Limitations 
           1.6 Stakeholders 
2. Research Methodology 
           2.1 Research Data 
                2.1.1 Secondary Data
                         2.1.1.1 Key Data from Secondary Sources
                2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
           2.2 Market Size Estimation 
           2.3 Market Breakdown and Data Triangulation 
           2.4 Assumptions for the Study  
3. Executive Summary
           3.1 Market Outlook
           3.2 Segment Outlook
           3.3 Competitive Insights
4. Market Variables, Trends & Scope
           4.1 Market Lineage Outlook
           4.2 Penetration and Growth Prospect Mapping
           4.3 Industry Value Chain Analysis
           4.4 Cost Analysis Breakdown
           4.5 Technology Overview
           4.6 Regulatory Framework on Country Level
                 4.6.1 Reimbursement Framework    
                 4.6.2 Standards and Compliances
5. Market Overview
           5.1 Market Dynamics
                 5.1.1 Market Driver Analysis         
                 5.1.2 Market Restraint Analysis         
                 5.1.3 Industry Challenges                   
6. Market Analysis tools                       
           6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
           6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. Multimodal Imaging Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
           7.1 PET-CT
           7.2 SPECT-CT
           7.3 PET-MR
           7.4 OCT
           7.5 Trimodal                    
8. Multimodal Imaging Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
           8.1 Cardiology
           8.2 Brain and Neurology
           8.3 Ophthalmology
           8.4 Oncology
           8.5 Others          
9. Multimodal Imaging Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
            9.1 Hospitals
            9.2 Diagnostic Imaging Centers
            9.3 Other End Users        
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            10.1. Introduction
            10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                10.2.1. U.S.
                10.2.2. Canada
                10.2.3. Mexico 
                10.2.4. Rest of North America
            10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            11.1. Introduction
            11.2. Regional Market Trends
            11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                11.3.1. Brazil
                11.3.2. Venezuela
                11.3.3. Argentina
                11.3.4. Rest of Latin America
            11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            12.1. Introduction
            12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.2.1. Germany
                12.2.2. U.K
                12.2.3. France
                12.2.4. Italy
                12.2.5 Switzerland
                12.2.6. Spain
                12.2.7. Russia
                12.2.8. Poland
                12.2.9. Rest of Western Europe
            12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            13.1 Introduction
            13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 13.2.1 Japan
                 13.2.2 China
                 13.2.3 Singapore
                 13.2.4 Korea         
                 13.2.5 India
                 13.2.6 Australia and New Zealand
                 13.2.7 ASEAN
                 13.2.8 Rest of Asia Pacific
            13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    14.1 Introduction
    14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
        14.2.1 UAE
        14.2.2 South Africa
        14.2.3 Egypt
        14.2.4 Saudi Arabia
        14.2.5 Rest of MEA
    14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    15.1 Koninklijke Philips N.V.
            15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.1.2. Product Portfolio
            15.1.3. SWOT Analysis
            15.1.4. Financial Overview
            15.1.5. Strategic Overview
    15.2 Canon Inc.
             15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.2. Product Portfolio
              15.2.3. SWOT Analysis
              15.2.4. Financial Overview
              15.2.5. Strategic Overview
    15.3 United Imaging Healthcare Co. Ltd.
              15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.3.2. Product Portfolio
              15.3.3. SWOT Analysis
              15.3.4. Financial Overview
              15.3.5. Strategic Overview
    15.4 Siemens
            15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.4.2. Product Portfolio
             15.4.3. SWOT Analysis
             15.4.4. Financial Overview
             15.4.5. Strategic Overview
    15.5 Mediso Medical Imaging Systems Kft
              15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.5.2. Product Portfolio
              15.5.3. SWOT Analysis
              15.5.4. Financial Overview
              15.5.5. Strategic Overview
    15.6 Neusoft Medical Systems Co. Ltd.
              15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.6.2. Product Portfolio
              15.6.3. SWOT Analysis
              15.6.4. Financial Overview
              15.6.5. Strategic Overview
    15.7 Infraredx Inc.
             15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.7.2. Product Portfolio
             15.7.3. SWOT Analysis
             15.7.4. Financial Overview
             15.7.5. Strategic Overview
    15.8 Spectrum Dynamics Medical
              15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.8.2. Product Portfolio
              15.8.3. SWOT Analysis
              15.8.4. Financial Overview
              15.8.5. Strategic Overview    
    15.9 Topcon Corporation
              15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.9.2. Product Portfolio
              15.9.3. SWOT Analysis
              15.9.4. Financial Overview
              15.9.5. Strategic Overview
    15.10 GE Healthcare
              15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.10.2. Product Portfolio
              15.10.3. SWOT Analysis
              15.10.4. Financial Overview
              15.10.5. Strategic Overview
    15.11 Heidelberg Engineering
              15.11.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.11.2. Product Portfolio
              15.11.3. SWOT Analysis
              15.11.4. Financial Overview
              15.11.5. Strategic Overview
    15.12 Carl Zeiss AG
             15.12.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.12.2. Product Portfolio
             15.12.3. SWOT Analysis
             15.12.4. Financial Overview
             15.12.5. Strategic Overview
    15.13 Optovue Inc.
            15.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.13.2. Product Portfolio
            15.13.3. SWOT Analysis
            15.13.4. Financial Overview
            15.13.5. Strategic Overview
    15.14 Nidek Co., Ltd.
            15.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.14.2. Product Portfolio
            15.14.3. SWOT Analysis
            15.14.4. Financial Overview
            15.14.5. Strategic Overview
     15.15 Optos Plc (UK) (a part of Nikon Corporation)
            15.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.15.2. Product Portfolio
            15.15.3. SWOT Analysis
            15.15.4. Financial Overview
            15.15.5. Strategic Overview
    15.15 Kowa Company Ltd.
            15.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.15.2. Product Portfolio
            15.15.3. SWOT Analysis
            15.15.4. Financial Overview
            15.15.5. Strategic Overview
16. Impact of COVID-19
      16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations
17. Competitive Intelligence and Competitive Matrix
      17.1 Competitive Intelligence
      17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
      18.1 Joint ventures
      18.2 Mergers and acquisitions              
      18.3 Licensing and partnerships
      18.4 Technology Collaborations
      18.5 Strategic Divestments
      18.6 Market Entry Strategies                        
19. Relevant Case Studies and Latest News Updates
20. Research Sources and List of Primary Contacts of this Study
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics 

Tables

Figures